Cartesian Therapeutics AAQS

What does Cartesian Therapeutics do? Cartesian Therapeutics Inc, trading under the ticker RNAC, is a biotechnology company based in Watertown, United States. The company has 75 employees and went public via an IPO on June 22, 2016. Cartesian Therapeutics operates within the Health Care sector, specifically in the Biotechnology industry. The company's website is https://selectabio.com/. Cartesian Therapeutics focuses on developing therapeutic solutions, though specific product names or clinical stage details are not provided in the available information. The company's headquarters are located in Watertown, and it is engaged in research and development activities typical of a biopharmaceutical firm. Cartesian Therapeutics is identified by its ISIN number US8162123025. The company's activities are centered around advancing biotechnology for healthcare applications, with a focus on innovative therapeutic approaches. The company's operational scope and specific research areas are not detailed beyond the general biotechnology sector focus. Cartesian Therapeutics is a clinical-stage biopharmaceutical company, though the exact stage of clinical development for any specific therapy is not specified in the provided data. The company's website serves as a primary source of information for further details on its operations and developments. Cartesian Therapeutics is one of the most popular companies on Eulerpool.